Clinical Trials Browser

Phase 1/2 × Unknown × IFL protocol × Clear all

NCT04247256 2022-03-02

A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI

Phase 1/2 Unknown

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms